,title,source,link,date
3,"Lupin collaborate with Amman Pharma for marketing, commercialization of Ranibizumab in Middle East region",Medical Dialogues,news.google.com/articles/CBMioAFodHRwczovL21lZGljYWxkaWFsb2d1ZXMuaW4vbmV3cy9pbmR1c3RyeS9waGFybWEvbHVwaW4tY29sbGFib3JhdGUtd2l0aC1hbW1hbi1waGFybWEtZm9yLW1hcmtldGluZy1jb21tZXJjaWFsaXphdGlvbi1vZi1yYW5pYml6dW1hYi1pbi1taWRkbGUtZWFzdC1yZWdpb24tMTIwMDQ50gGkAWh0dHBzOi8vbWVkaWNhbGRpYWxvZ3Vlcy5pbi9hbXAvbmV3cy9pbmR1c3RyeS9waGFybWEvbHVwaW4tY29sbGFib3JhdGUtd2l0aC1hbW1hbi1waGFybWEtZm9yLW1hcmtldGluZy1jb21tZXJjaWFsaXphdGlvbi1vZi1yYW5pYml6dW1hYi1pbi1taWRkbGUtZWFzdC1yZWdpb24tMTIwMDQ5?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-11
23,These 45 smallcap stocks gain 15-40% as Sensex logs second weekly gain led by global cues; do you own? | Mint,Mint,news.google.com/articles/CBMiqwFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL3RoZXNlLTQ1LXNtYWxsY2FwLXN0b2Nrcy1nYWluZWQtMTUtNDAtYXMtc2Vuc2V4LWxvZ3Mtc2Vjb25kLXdlZWtseS1nYWluLWxlZC1ieS1nbG9iYWwtY3Vlcy1kby15b3Utb3duLTExNjk5NzExNzgxMTE1Lmh0bWzSAa8BaHR0cHM6Ly93d3cubGl2ZW1pbnQuY29tL21hcmtldC9zdG9jay1tYXJrZXQtbmV3cy90aGVzZS00NS1zbWFsbGNhcC1zdG9ja3MtZ2FpbmVkLTE1LTQwLWFzLXNlbnNleC1sb2dzLXNlY29uZC13ZWVrbHktZ2Fpbi1sZWQtYnktZ2xvYmFsLWN1ZXMtZG8teW91LW93bi9hbXAtMTE2OTk3MTE3ODExMTUuaHRtbA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-11
0,"Lupin, Amman Pharma collaborates for exclusive marketing of Ranibizumab",Business Standard,news.google.com/articles/CBMiiwFodHRwczovL3d3dy5idXNpbmVzcy1zdGFuZGFyZC5jb20vY29tcGFuaWVzL25ld3MvbHVwaW4tYW1tYW4tcGhhcm1hLWNvbGxhYm9yYXRlcy1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1yYW5pYml6dW1hYi0xMjMxMTEwMDA1MTFfMS5odG1s0gGPAWh0dHBzOi8vd3d3LmJ1c2luZXNzLXN0YW5kYXJkLmNvbS9hbXAvY29tcGFuaWVzL25ld3MvbHVwaW4tYW1tYW4tcGhhcm1hLWNvbGxhYm9yYXRlcy1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1yYW5pYml6dW1hYi0xMjMxMTEwMDA1MTFfMS5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
1,Lupin and Amman Pharma sign licensing agreement for Ranibizumab biosimilar,Moneycontrol,news.google.com/articles/CBMiigFodHRwczovL3d3dy5tb25leWNvbnRyb2wuY29tL25ld3MvYnVzaW5lc3Mvc3RvY2tzL2x1cGluLWFuZC1hbW1hbi1waGFybWEtc2lnbi1saWNlbnNpbmctYWdyZWVtZW50LWZvci1yYW5pYml6dW1hYi1iaW9zaW1pbGFyLTExNzE3NjIxLmh0bWzSAY4BaHR0cHM6Ly93d3cubW9uZXljb250cm9sLmNvbS9uZXdzL2J1c2luZXNzL3N0b2Nrcy9sdXBpbi1hbmQtYW1tYW4tcGhhcm1hLXNpZ24tbGljZW5zaW5nLWFncmVlbWVudC1mb3ItcmFuaWJpenVtYWItYmlvc2ltaWxhci0xMTcxNzYyMS5odG1sL2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
2,"Lupin, Amman Pharma ink pact for exclusive marketing of drug used in treatment of eye problems",CNBCTV18,news.google.com/articles/CBMilgFodHRwczovL3d3dy5jbmJjdHYxOC5jb20vYnVzaW5lc3MvY29tcGFuaWVzL2x1cGluLWFtbWFuLXBoYXJtYS1pbmstcGFjdC1mb3ItZXhjbHVzaXZlLW1hcmtldGluZy1vZi1kcnVnLXVzZWQtaW4tdHJlYXRtZW50LW9mLWV5ZS1wcm9ibGVtcy0xODI5NzMwMS5odG3SAZoBaHR0cHM6Ly93d3cuY25iY3R2MTguY29tL2J1c2luZXNzL2NvbXBhbmllcy9sdXBpbi1hbW1hbi1waGFybWEtaW5rLXBhY3QtZm9yLWV4Y2x1c2l2ZS1tYXJrZXRpbmctb2YtZHJ1Zy11c2VkLWluLXRyZWF0bWVudC1vZi1leWUtcHJvYmxlbXMtMTgyOTczMDEuaHRtL2FtcA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
4,Lupin And Amman Pharma Sign Exclusive Licensing And Supply Agreement For Ranibizumab Biosimilar,Free Press Journal,news.google.com/articles/CBMiiAFodHRwczovL3d3dy5mcmVlcHJlc3Nqb3VybmFsLmluL2J1c2luZXNzL2x1cGluLWFuZC1hbW1hbi1waGFybWEtc2lnbi1leGNsdXNpdmUtbGljZW5zaW5nLWFuZC1zdXBwbHktYWdyZWVtZW50LWZvci1yYW5pYml6dW1hYi1iaW9zaW1pbGFy0gGMAWh0dHBzOi8vd3d3LmZyZWVwcmVzc2pvdXJuYWwuaW4vYW1wL2J1c2luZXNzL2x1cGluLWFuZC1hbW1hbi1waGFybWEtc2lnbi1leGNsdXNpdmUtbGljZW5zaW5nLWFuZC1zdXBwbHktYWdyZWVtZW50LWZvci1yYW5pYml6dW1hYi1iaW9zaW1pbGFy?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
6,Lupin and Amman Pharma Sign Exclusive Licensing and Supply ...,Lupin,news.google.com/articles/CBMidmh0dHBzOi8vd3d3Lmx1cGluLmNvbS9sdXBpbi1hbmQtYW1tYW4tcGhhcm1hLXNpZ24tZXhjbHVzaXZlLWxpY2Vuc2luZy1hbmQtc3VwcGx5LWFncmVlbWVudC1mb3ItcmFuaWJpenVtYWItYmlvc2ltaWxhci_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
38,Balsalazide Industry is Booming Globally by 2030 | Salix ...,Argyle Report,news.google.com/articles/CBMiigFodHRwczovL3d3dy5hcmd5bGVyZXBvcnQuY29tL25ld3MvYmFsc2FsYXppZGUtaW5kdXN0cnktaXMtYm9vbWluZy1nbG9iYWxseS1ieS0yMDMwLXNhbGl4LXBoYXJtYWNldXRpY2Fsc2JhdXNjaC1oZWFsdGgtYW50ZXItYXBvdGV4LzM2NjgwNS_SAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-10
71,"Active Pharmaceutical Ingredients CDMO Market worth $229.39 billion by 2030, growing at a CAGR of 10.32% - Exc",openPR,news.google.com/articles/CBMiXmh0dHBzOi8vd3d3Lm9wZW5wci5jb20vbmV3cy8zMjgyMTg0L2FjdGl2ZS1waGFybWFjZXV0aWNhbC1pbmdyZWRpZW50cy1jZG1vLW1hcmtldC13b3J0aC0yMjktMznSAV1odHRwczovL3d3dy5vcGVucHIuY29tL2FtcC8zMjgyMTg0L2FjdGl2ZS1waGFybWFjZXV0aWNhbC1pbmdyZWRpZW50cy1jZG1vLW1hcmtldC13b3J0aC0yMjktMzk?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
16,"Stocks to Watch: Power Finance, Tata Power, Lupin, Raymond, HAL, Bata India | Mint",Mint,news.google.com/articles/CBMiiwFodHRwczovL3d3dy5saXZlbWludC5jb20vbWFya2V0L3N0b2NrLW1hcmtldC1uZXdzL3N0b2Nrcy10by13YXRjaC1wb3dlci1maW5hbmNlLXRhdGEtcG93ZXItbHVwaW4tcmF5bW9uZC1oYWwtYmF0YS1pbmRpYS0xMTY5OTQ5MTk3NTI5Mi5odG1s0gGPAWh0dHBzOi8vd3d3LmxpdmVtaW50LmNvbS9tYXJrZXQvc3RvY2stbWFya2V0LW5ld3Mvc3RvY2tzLXRvLXdhdGNoLXBvd2VyLWZpbmFuY2UtdGF0YS1wb3dlci1sdXBpbi1yYXltb25kLWhhbC1iYXRhLWluZGlhL2FtcC0xMTY5OTQ5MTk3NTI5Mi5odG1s?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-11-09
